E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/5/2009 in the Prospect News PIPE Daily.

New Issue: Optimer plans $32.95 million direct offerings of stock, units

By Devika Patel

Knoxville, Tenn., March 5 - Optimer Pharmaceuticals, Inc. arranged a $5 million direct offering of units and a $27.95 million direct offering of stock on March 4, according to two prospectus supplements filed with the Securities and Exchange Commission.

The company will sell 457,666 units at $10.925 each and 2,794,700 shares at $10.00 apiece.

The units consist of one common share and one warrant for 0.20 of a share. Each whole warrant is exercisable at $10.93 for five years.

Settlement of both deals is expected March 9.

Proceeds will be used primarily to fund clinical and pre-clinical development of Optimer's product candidates, preparation and submission of regulatory filings related to the company's product candidates, pre-launch commercialization and marketing activities, a milestone payment of $5 million to Par Pharmaceutical, Inc. and for general corporate purposes.

San Diego-based Optimer Pharmaceuticals is a biopharmaceutical company specializing on the discovering, developing and commercializing of innovative treatments.

Issuer:Optimer Pharmaceuticals, Inc.
Issue:Common stock, units of one common share and one warrant for 0.20 of a share
Amount:$32,947,001
Pricing date:March 4
Settlement date:March 9
Stock symbol:Nasdaq: OPTR
Stock price:$10.93 at close March 4
Market capitalization:$321 million
Shares
Amount:$27,947,000
Shares:2,794,700
Price:$10.00
Warrants:No
Units
Amount:$5,000,001
Units:457,666
Price:$10.925
Warrants:One warrant for 0.20 of a share per unit
Warrant expiration:Five years
Warrant strike price:$10.93

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.